•
Dec 31, 2021

REGENXBIO Q4 2021 Earnings Report

Total Revenue
$399M
Previous year: $21.4M
+1759.0%
EPS
$6.67
Previous year: -$1.24
-637.9%
Gross Profit
$376M
Previous year: $11.2M
+3257.1%
Cash and Equivalents
$345M
Previous year: $338M
+2.0%
Free Cash Flow
$312M
Previous year: $26.6M
+1072.4%
Total Assets
$1.11B
Previous year: $708M
+57.3%

REGENXBIO

REGENXBIO